Previous studies have suggested that CB1 activation promotes atherosclerosis by inducing inflammation and oxidative stress, leading to endothelial dysfunction, whereas CB2 activation exerts antiatherogenic effects [19]. The gene discussed is CNR1; the disease is endothelial dysfunction.